Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $338.14M.
ENTERPRISE VALUE (EV)
$338.14M
Carlsmed, Inc.
Market Cap
$408.59M
Enterprise Value (EV)
$338.14M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Carlsmed, Inc. (CARL) | $408.59M | $338.14M |
| Myriad Genetics, Inc. (MYGN)vs › | $408.56M | $503.86M |
| Shoulder Innovations, Inc. (SI)vs › | $409.79M | $400.18M |
| Neurogene Inc. (NGNE)vs › | $412.44M | $308.30M |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $414.54M | $338.42M |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $415.97M | $525.17M |
| Prothena Corporation plc (PRTA)vs › | $419.87M | $138.67M |
| Senseonics Holdings, Inc. (SENS)vs › | $422.12M | $439.21M |
| Rezolute, Inc. (RZLT)vs › | $423.69M | $414.01M |
| MapLight Therapeutics, Inc. (MPLT)vs › | $393.38M | $323.74M |
Market Cap
$408.59M
Total Debt
$15.35M
Cash
$85.79M
Enterprise Value
$338.14M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
